APA (7th ed.) Citation

K, K., A, J., MA, T., L, Y., MK, S., YT, T., . . . U, O. (2023). Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma. Blood cancer journal, 13(1), 12. https://doi.org/10.1038/s41408-023-00787-w

Chicago Style (17th ed.) Citation

K, Kurata, et al. "Prolyl-tRNA Synthetase as a Novel Therapeutic Target in Multiple Myeloma." Blood Cancer Journal 13, no. 1 (2023): 12. https://doi.org/10.1038/s41408-023-00787-w.

MLA (9th ed.) Citation

K, Kurata, et al. "Prolyl-tRNA Synthetase as a Novel Therapeutic Target in Multiple Myeloma." Blood Cancer Journal, vol. 13, no. 1, 2023, p. 12, https://doi.org/10.1038/s41408-023-00787-w.